speb/financial-data huggingface dataset:
ZENA.OL income_statement (annual, 2023-03-31) — Other Special Charges: 1424000.00
ZENA.OL income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Payables: 22461000.00
ZENA.OL income_statement (annual, 2023-03-31) — Pretax Income: -12210000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
ZENA.OL cash_flow (annual, 2023-03-31) — Purchase Of PPE: -430000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Raw Materials: 5591000.00
ZENA.OL income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 10497000.00
ZENA.OL income_statement (annual, 2023-03-31) — Reconciled Depreciation: 4747000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Repayment Of Debt: -5799000.00
ZENA.OL income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 1700000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Retained Earnings: 16795000.00
ZENA.OL income_statement (annual, 2023-03-31) — Selling General And Administration: 8730000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Share Issued: 231030253.00
ZENA.OL income_statement (annual, 2023-03-31) — Special Income Charges: -6239000.00
ZENA.OL cash_flow (annual, 2023-03-31) — Stock Based Compensation: 733000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Stockholders Equity: 91652000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Tangible Book Value: 91652000.00
ZENA.OL income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -2495600.00
ZENA.OL income_statement (annual, 2023-03-31) — Tax Provision: 617000.00
ZENA.OL income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.40
ZENA.OL balance_sheet (annual, 2023-03-31) — Total Assets: 262911000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Total Capitalization: 116899000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Total Debt: 33944000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 91652000.00
ZENA.OL income_statement (annual, 2023-03-31) — Total Expenses: 22340000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 171259000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 228345000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 140101000.00
ZENA.OL income_statement (annual, 2023-03-31) — Total Operating Income As Reported: -5934000.00
ZENA.OL income_statement (annual, 2023-03-31) — Total Unusual Items: -6239000.00
ZENA.OL income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -6239000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 67372000.00
ZENA.OL balance_sheet (annual, 2023-03-31) — Working Capital: 3408000.00
ZENA.OL income_statement (annual, 2023-03-31) — Write Off: 1146000.00
ZENA.OL income_statement (annual, 2024-03-31) — +Operating Expense: 11087000.00
ZENA.OL income_statement (annual, 2024-03-31) — +Total Revenue: 1788000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Accounts Payable: 4002000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Accounts Receivable: 952000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 7389000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
ZENA.OL income_statement (annual, 2024-03-31) — Basic Average Shares: 269229000.00
ZENA.OL income_statement (annual, 2024-03-31) — Basic EPS: -0.16
ZENA.OL cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1442000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Capital Expenditure: -53000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Capital Stock: 66224000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 207000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 207000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Change In Inventory: 4417000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Change In Payable: -13202000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: 181000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Change In Receivables: 23714000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Change In Working Capital: 15110000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Changes In Cash: -1235000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Common Stock: 66224000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Common Stock Equity: 49978000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Common Stock Issuance: 2137000.00
ZENA.OL income_statement (annual, 2024-03-31) — Cost Of Revenue: 5023000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Current Assets: 5018000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Current Debt: 9492000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 9492000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Current Liabilities: 16740000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Depreciation: 3938000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 3938000.00
ZENA.OL income_statement (annual, 2024-03-31) — Diluted Average Shares: 269229000.00
ZENA.OL income_statement (annual, 2024-03-31) — Diluted EPS: -0.16
ZENA.OL income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -42367000.00
ZENA.OL income_statement (annual, 2024-03-31) — EBIT: -37359000.00
ZENA.OL income_statement (annual, 2024-03-31) — EBITDA: -33421000.00
ZENA.OL cash_flow (annual, 2024-03-31) — End Cash Position: 207000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Financing Cash Flow: 3548000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Finished Goods: 1886000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Free Cash Flow: -4243000.00
ZENA.OL income_statement (annual, 2024-03-31) — General And Administrative Expense: 8937000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 540000.00
ZENA.OL income_statement (annual, 2024-03-31) — Gross Profit: -3235000.00
ZENA.OL income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
ZENA.OL income_statement (annual, 2024-03-31) — Interest Expense: 5008000.00
ZENA.OL income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 5008000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Interest Paid Cff: -4857000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Inventory: 2031000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Invested Capital: 91662000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Investing Cash Flow: -593000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 0.00
ZENA.OL cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 2137000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Issuance Of Debt: 17577000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Long Term Debt: 32192000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 32192000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 17577000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -11309000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Long Term Provisions: 23301000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -540000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 2137000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Net Debt: 41477000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 1436000.00
ZENA.OL income_statement (annual, 2024-03-31) — Net Income: -42367000.00
ZENA.OL income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -42367000.00
ZENA.OL income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -42367000.00
ZENA.OL income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -42367000.00
ZENA.OL income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -42367000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -42367000.00
ZENA.OL income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -42367000.00
ZENA.OL income_statement (annual, 2024-03-31) — Net Interest Income: -5008000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 6268000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 6268000.00
ZENA.OL income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -5008000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Net PPE: 134460000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -53000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 49438000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 2398000.00
ZENA.OL income_statement (annual, 2024-03-31) — Normalized EBITDA: -13267000.00
ZENA.OL income_statement (annual, 2024-03-31) — Normalized Income: -22213000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Operating Cash Flow: -4190000.00
ZENA.OL income_statement (annual, 2024-03-31) — Operating Income: -14322000.00
ZENA.OL income_statement (annual, 2024-03-31) — Operating Revenue: 1788000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 271545401.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Other Equity Interest: 3381000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Other Non Cash Items: -6184000.00
ZENA.OL income_statement (annual, 2024-03-31) — Other Operating Expenses: 402000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Other Payable: 3246000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Other Receivables: 1828000.00
ZENA.OL income_statement (annual, 2024-03-31) — Other Special Charges: 2340000.00
ZENA.OL income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Payables: 7248000.00
ZENA.OL income_statement (annual, 2024-03-31) — Pretax Income: -42367000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Purchase Of Business: -540000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Purchase Of PPE: -53000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Raw Materials: 145000.00
ZENA.OL income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 5023000.00
ZENA.OL income_statement (annual, 2024-03-31) — Reconciled Depreciation: 3938000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Repayment Of Debt: -11309000.00
ZENA.OL income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 1566000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Retained Earnings: -27016000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
ZENA.OL income_statement (annual, 2024-03-31) — Selling General And Administration: 8937000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Share Issued: 271545401.00
ZENA.OL income_statement (annual, 2024-03-31) — Special Income Charges: -22287000.00
ZENA.OL cash_flow (annual, 2024-03-31) — Stock Based Compensation: 0.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Stockholders Equity: 49978000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Tangible Book Value: 49438000.00
ZENA.OL income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
ZENA.OL income_statement (annual, 2024-03-31) — Tax Provision: 0.00
ZENA.OL income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Total Assets: 140018000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Total Capitalization: 82170000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Total Debt: 41684000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 49978000.00
ZENA.OL income_statement (annual, 2024-03-31) — Total Expenses: 16110000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 90040000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 135000000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 73300000.00
ZENA.OL income_statement (annual, 2024-03-31) — Total Operating Income As Reported: -27636000.00
ZENA.OL income_statement (annual, 2024-03-31) — Total Unusual Items: -20154000.00
ZENA.OL income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -20154000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 15409000.00
ZENA.OL balance_sheet (annual, 2024-03-31) — Working Capital: -11722000.00
ZENA.OL income_statement (annual, 2024-03-31) — Write Off: 18381000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 5535000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1087000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 7573000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Capital Stock: 66224000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 86000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 86000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Common Stock: 66224000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 53741000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Current Assets: 14382000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Current Debt: 9263000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 9263000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 17313000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Finished Goods: 2086000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Inventory: 2086000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Invested Capital: 102176000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 0.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 39172000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 39172000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 23950000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Net Debt: 48349000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Net PPE: 137601000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 53741000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 2398000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 271545401.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 3197000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Other Payable: 2515000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Other Receivables: 11123000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Payables: 8050000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Retained Earnings: -23253000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Share Issued: 271545401.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 53741000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 53741000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Total Assets: 151983000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 92913000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Total Debt: 48435000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 53741000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 98242000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 137601000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 80929000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 15409000.00
ZENA.OL balance_sheet (quarterly, 2024-09-30) — Working Capital: -2931000.00
ZENA.OL income_statement (annual, 2025-03-31) — +Operating Expense: 4161000.00
ZENA.OL income_statement (annual, 2025-03-31) — +Total Revenue: 2147000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Accounts Payable: 7503000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 7503000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1257000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1257000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 7573000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7573000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 5476000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 5476000.00
ZENA.OL income_statement (annual, 2025-03-31) — Basic Average Shares: 330000000.00
ZENA.OL income_statement (annual, 2025-03-31) — Basic EPS: 0.00
ZENA.OL cash_flow (annual, 2025-03-31) — Beginning Cash Position: 207000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Capital Expenditure: -417000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Capital Stock: 81201000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 81201000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 3199000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3199000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3199000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3199000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Change In Inventory: -381000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Change In Payable: 3079000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: 115000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Change In Receivables: -16466000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Change In Working Capital: -13653000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Changes In Cash: 2992000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Common Stock: 81201000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Common Stock: 81201000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Common Stock Equity: 65629000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 65629000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Common Stock Issuance: 14977000.00
ZENA.OL income_statement (annual, 2025-03-31) — Cost Of Revenue: 2067000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Current Assets: 30219000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Current Assets: 30219000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Current Debt: 14320000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Current Debt: 14320000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 14320000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 14320000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Current Liabilities: 23011000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 23011000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Deferred Tax: 0.00
ZENA.OL cash_flow (annual, 2025-03-31) — Depreciation: 366000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 366000.00
ZENA.OL income_statement (annual, 2025-03-31) — Diluted Average Shares: 330000000.00
ZENA.OL income_statement (annual, 2025-03-31) — Diluted EPS: 0.00
ZENA.OL income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1089000.00
ZENA.OL income_statement (annual, 2025-03-31) — EBIT: 3599000.00
ZENA.OL income_statement (annual, 2025-03-31) — EBITDA: 3965000.00
ZENA.OL cash_flow (annual, 2025-03-31) — End Cash Position: 3199000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Financing Cash Flow: 12714000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Finished Goods: 2412000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Finished Goods: 2412000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Free Cash Flow: -11383000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 3725000.00
ZENA.OL income_statement (annual, 2025-03-31) — General And Administrative Expense: 2638000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
ZENA.OL income_statement (annual, 2025-03-31) — Gross Profit: 80000.00
ZENA.OL income_statement (annual, 2025-03-31) — Interest Expense: 2510000.00
ZENA.OL income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 2510000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Interest Paid Cff: -6976000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Inventory: 2412000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Inventory: 2412000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Invested Capital: 114126000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 114126000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Investing Cash Flow: 1244000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 14977000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Issuance Of Debt: 6338000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Long Term Debt: 34177000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 34177000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 34177000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 34177000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 6338000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -1625000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Long Term Provisions: 24091000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 24091000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
ZENA.OL cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 14977000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Net Debt: 45298000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Net Debt: 45298000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -8209000.00
ZENA.OL income_statement (annual, 2025-03-31) — Net Income: 1089000.00
ZENA.OL income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1089000.00
ZENA.OL income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1089000.00
ZENA.OL income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1089000.00
ZENA.OL income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1089000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1089000.00
ZENA.OL income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1089000.00
ZENA.OL income_statement (annual, 2025-03-31) — Net Interest Income: -7954000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 4713000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 4713000.00
ZENA.OL income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -7954000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Net PPE: 134496000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Net PPE: 134496000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 1244000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 65629000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 65629000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2398000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2398000.00
ZENA.OL income_statement (annual, 2025-03-31) — Normalized EBITDA: 14855000.00
ZENA.OL income_statement (annual, 2025-03-31) — Normalized Income: 11979000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Operating Cash Flow: -10966000.00
ZENA.OL income_statement (annual, 2025-03-31) — Operating Income: -4081000.00
ZENA.OL income_statement (annual, 2025-03-31) — Operating Revenue: 2147000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 466873954.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 466873954.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Other Equity Interest: 6922000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 6922000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Other Non Cash Items: 5716000.00
ZENA.OL income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 15857000.00
ZENA.OL income_statement (annual, 2025-03-31) — Other Operating Expenses: 416000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Other Payable: 1188000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Other Payable: 1188000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Other Receivables: 17875000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Other Receivables: 17875000.00
ZENA.OL income_statement (annual, 2025-03-31) — Other Special Charges: 9123000.00
ZENA.OL income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Payables: 8691000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Payables: 8691000.00
ZENA.OL income_statement (annual, 2025-03-31) — Pretax Income: 1089000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
ZENA.OL cash_flow (annual, 2025-03-31) — Purchase Of PPE: -417000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Raw Materials: 0.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Raw Materials: 0.00
ZENA.OL income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 2067000.00
ZENA.OL income_statement (annual, 2025-03-31) — Reconciled Depreciation: 366000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1625000.00
ZENA.OL income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 1767000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Retained Earnings: -30067000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -30067000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Sale Of PPE: 1661000.00
ZENA.OL income_statement (annual, 2025-03-31) — Selling General And Administration: 2638000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Share Issued: 466873954.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Share Issued: 466873954.00
ZENA.OL income_statement (annual, 2025-03-31) — Special Income Charges: -10890000.00
ZENA.OL cash_flow (annual, 2025-03-31) — Stock Based Compensation: 3725000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Stockholders Equity: 65629000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 65629000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Tangible Book Value: 65629000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 65629000.00
ZENA.OL income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ZENA.OL income_statement (annual, 2025-03-31) — Tax Provision: 0.00
ZENA.OL income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Total Assets: 164715000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Total Assets: 164715000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Total Capitalization: 99806000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 99806000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Total Debt: 48497000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Total Debt: 48497000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 65629000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 65629000.00
ZENA.OL income_statement (annual, 2025-03-31) — Total Expenses: 6228000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 99086000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 99086000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 134496000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 134496000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 76075000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 76075000.00
ZENA.OL income_statement (annual, 2025-03-31) — Total Operating Income As Reported: -6398000.00
ZENA.OL income_statement (annual, 2025-03-31) — Total Other Finance Cost: 5444000.00
ZENA.OL income_statement (annual, 2025-03-31) — Total Unusual Items: -10890000.00
ZENA.OL income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -10890000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 15409000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 15409000.00
ZENA.OL balance_sheet (annual, 2025-03-31) — Working Capital: 7208000.00
ZENA.OL balance_sheet (quarterly, 2025-03-31) — Working Capital: 7208000.00
ZENA.OL income_statement (annual, 2025-03-31) — Write Off: 0.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5774000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1270000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7639000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 5476000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Capital Stock: 89743000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2414000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2414000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Common Stock: 89743000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 75507000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Current Assets: 39839000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Current Debt: 25698000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 25698000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 32647000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Finished Goods: 2497000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Inventory: 2497000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Invested Capital: 128945000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 27740000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 27740000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 25069000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Net Debt: 51024000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Net PPE: 138931000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 75507000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2398000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 548290222.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 6856000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Other Payable: 1175000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Other Receivables: 28182000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Payables: 6949000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -28731000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Share Issued: 548290222.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 75507000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 75507000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Total Assets: 178770000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 103247000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Total Debt: 53438000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 75507000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 103263000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 138931000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 70616000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 15409000.00
ZENA.OL balance_sheet (quarterly, 2025-09-30) — Working Capital: 7192000.00
ZENA.OL income_statement (annual, 2026-03-31) — +Operating Expense: 5714000.00
ZENA.OL income_statement (annual, 2026-03-31) — +Total Revenue: 2334000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Accounts Payable: 10883000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 10883000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Accounts Receivable: 19782000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 19782000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 9555000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 9555000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 5476000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 5476000.00
ZENA.OL income_statement (annual, 2026-03-31) — Basic Average Shares: 569903000.00
ZENA.OL income_statement (annual, 2026-03-31) — Basic EPS: -0.04
ZENA.OL cash_flow (annual, 2026-03-31) — Beginning Cash Position: 3199000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Capital Expenditure: -1414000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Capital Stock: 95794000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 95794000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 2067000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2067000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2067000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2067000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Change In Inventory: -56000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Change In Payable: 2448000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: -21000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Change In Receivables: -629000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Change In Working Capital: 1742000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Changes In Cash: -1132000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Common Stock: 95794000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Common Stock: 95794000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Common Stock Equity: 89692000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 89692000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Common Stock Issuance: 14594000.00
ZENA.OL income_statement (annual, 2026-03-31) — Cost Of Revenue: 1820000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Current Assets: 29793000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Current Assets: 29793000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Current Debt: 4840000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Current Debt: 4840000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 4840000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4840000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Current Liabilities: 15940000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 15940000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Deferred Tax: -95000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Depreciation: 383000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 383000.00
ZENA.OL income_statement (annual, 2026-03-31) — Diluted Average Shares: 654141000.00
ZENA.OL income_statement (annual, 2026-03-31) — Diluted EPS: -0.04
ZENA.OL income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -19923000.00
ZENA.OL income_statement (annual, 2026-03-31) — EBIT: -13048000.00
ZENA.OL income_statement (annual, 2026-03-31) — EBITDA: -12665000.00
ZENA.OL cash_flow (annual, 2026-03-31) — End Cash Position: 2067000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Financing Cash Flow: 12105000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Finished Goods: 2468000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Finished Goods: 2468000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Fixed Assets Revaluation Reserve: 29529000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Fixed Assets Revaluation Reserve: 29529000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Free Cash Flow: -13237000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 1397000.00
ZENA.OL income_statement (annual, 2026-03-31) — General And Administrative Expense: 3983000.00
ZENA.OL income_statement (annual, 2026-03-31) — Gross Profit: 514000.00
ZENA.OL income_statement (annual, 2026-03-31) — Interest Expense: 6780000.00
ZENA.OL income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 6780000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Interest Paid Cff: -7030000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Inventory: 2468000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Inventory: 2468000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Invested Capital: 143555000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 143555000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1414000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 14594000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Issuance Of Debt: 8323000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Long Term Debt: 49023000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 49023000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 49023000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 49023000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 8323000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -3780000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Long Term Provisions: 25153000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 25153000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 14594000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Net Debt: 51796000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Net Debt: 51796000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -3544000.00
ZENA.OL income_statement (annual, 2026-03-31) — Net Income: -19923000.00
ZENA.OL income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -19923000.00
ZENA.OL income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -19923000.00
ZENA.OL income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -19923000.00
ZENA.OL income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -19923000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -19828000.00
ZENA.OL income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -19923000.00
ZENA.OL income_statement (annual, 2026-03-31) — Net Interest Income: -7683000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 4543000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 4543000.00
ZENA.OL income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -7683000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -2000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Net PPE: 167822000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Net PPE: 167822000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1414000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 89692000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 89692000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2398000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2398000.00
ZENA.OL income_statement (annual, 2026-03-31) — Normalized EBITDA: -398000.00
ZENA.OL income_statement (annual, 2026-03-31) — Normalized Income: -12562800.00
ZENA.OL cash_flow (annual, 2026-03-31) — Operating Cash Flow: -11823000.00
ZENA.OL income_statement (annual, 2026-03-31) — Operating Income: -5200000.00
ZENA.OL income_statement (annual, 2026-03-31) — Operating Revenue: 2334000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 649182327.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 649182327.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Other Equity Interest: 6337000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 6337000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Other Non Cash Items: 8122000.00
ZENA.OL income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 1969000.00
ZENA.OL income_statement (annual, 2026-03-31) — Other Operating Expenses: 439000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Other Payable: 217000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Other Payable: 217000.00
ZENA.OL income_statement (annual, 2026-03-31) — Other Special Charges: 12138000.00
ZENA.OL income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Payables: 11100000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Payables: 11100000.00
ZENA.OL income_statement (annual, 2026-03-31) — Pretax Income: -19828000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1414000.00
ZENA.OL income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 1820000.00
ZENA.OL income_statement (annual, 2026-03-31) — Reconciled Depreciation: 383000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Repayment Of Debt: -3780000.00
ZENA.OL income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 129000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Retained Earnings: -51523000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -51523000.00
ZENA.OL cash_flow (annual, 2026-03-31) — Sale Of PPE: 0.00
ZENA.OL income_statement (annual, 2026-03-31) — Selling General And Administration: 3983000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Share Issued: 649182327.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Share Issued: 649182327.00
ZENA.OL income_statement (annual, 2026-03-31) — Special Income Charges: -12267000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Stockholders Equity: 89692000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 89692000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Tangible Book Value: 89692000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 89692000.00
ZENA.OL income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -4906800.00
ZENA.OL income_statement (annual, 2026-03-31) — Tax Provision: 95000.00
ZENA.OL income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
ZENA.OL balance_sheet (annual, 2026-03-31) — Total Assets: 197615000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Total Assets: 197615000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Total Capitalization: 138715000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 138715000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Total Debt: 53863000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Total Debt: 53863000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 89692000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 89692000.00
ZENA.OL income_statement (annual, 2026-03-31) — Total Expenses: 7534000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 107923000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 107923000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 167822000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 167822000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 91983000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 91983000.00
ZENA.OL income_statement (annual, 2026-03-31) — Total Operating Income As Reported: -13675000.00
ZENA.OL income_statement (annual, 2026-03-31) — Total Other Finance Cost: 903000.00
ZENA.OL income_statement (annual, 2026-03-31) — Total Unusual Items: -12267000.00
ZENA.OL income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -12267000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Tradeand Other Payables Non Current: 15409000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 15409000.00
ZENA.OL balance_sheet (annual, 2026-03-31) — Working Capital: 13853000.00
ZENA.OL balance_sheet (quarterly, 2026-03-31) — Working Capital: 13853000.00
ZENB.L income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -27590000000.00
ZENB.L income_statement (annual, 2022-12-31) — +Operating Expense: 339692000000.00
ZENB.L income_statement (annual, 2022-12-31) — +Total Revenue: 658622000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 365982000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -191529000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 255047000000.00
ZENB.L income_statement (annual, 2022-12-31) — Amortization: 3678000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 3679000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 2719391000000.00
ZENB.L income_statement (annual, 2022-12-31) — Basic Average Shares: 630115524.00
ZENB.L income_statement (annual, 2022-12-31) — Basic EPS: 355.76
ZENB.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1134519000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 121244000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -73656000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Capital Stock: 15698000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3558302000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 3693838000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -97371000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Cash Financial: 85437000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -478297000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 48387000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Change In Working Capital: 1042983000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Changes In Cash: 718284000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Common Stock: 15698000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -97371000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1378127000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Construction In Progress: 43419000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Depreciation: 26630000000.00
ZENB.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 30309000000.00
ZENB.L income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 30308000000.00
ZENB.L income_statement (annual, 2022-12-31) — Depreciation Income Statement: 26630000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 6325000000.00
ZENB.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 630115524.00
ZENB.L income_statement (annual, 2022-12-31) — Diluted EPS: 355.76
ZENB.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 224050000000.00
ZENB.L balance_sheet (annual, 2022-12-31) — Dividends Payable: 29764000000.00